<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR137">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Oe</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Hayashi</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Fushima</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Sato</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Kisu</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Sato</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Ito</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Takahashi</surname>
    <given-names>N</given-names>
   </name>
  </person-group>
  <article-title>Coagulation Factor Xa and Protease-Activated Receptor 2 as novel therapeutic targets for diabetic nephropathy</article-title>
  <source>Arterioscler Thromb Vasc Biol</source>
  <year>2016</year>
  <volume>36</volume>
  <fpage>1525</fpage>
  <lpage>1533</lpage>
  <pub-id pub-id-type="doi">10.1161/ATVBAHA.116.307883</pub-id>
  <?supplied-pmid 27283743?>
  <pub-id pub-id-type="pmid">27283743</pub-id>
 </element-citation>
</ref>
